Follow The Filings

MOLN Molecular Partners

Molecular Partners earnings company data as of 5:01 PM ET 10/23

Scheduled

2 periods, newest first, nothing reported yet. Each row shows EPS above revenue.

Period Date Metric Estimate Actual Result
FY2026 Q3 29 Oct EPS — — —
Rev — — —
FY2026 Q2 25 Aug EPS -0.35 — —
Rev — — —

SEC filings

Recent issuer filings from EDGAR, 25 shown.

Filed Form Detail Links
6-K
6-K FORM 6-K
6-K FORM 6-K
6-K FORM 6-K
6-K FORM 6-K
6-K
6-K FORM 6-K
6-K FORM 6-K
6-K
6-K FORM 6-K
20-F
6-K
6-K FORM 6-K
6-K FORM 6-K
6-K FORM 6-K
6-K FORM 6-K
6-K
6-K
SCHEDULE 13G —
6-K
6-K
SCHEDULE 13G —
6-K
20-F
6-K

Estimates are consensus figures; SEC filings remain the official record. Not investment advice.